01774nam a2200349 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020001800112020001800130020002600148020002700174040002100201035002100222050002300243245012700266250001200393260003500405300003600440504005100476505048700527533015201014650002801166650002201194655002901216700002301245710001701268856012601285999001301411ebr10713652CaPaEBRm     o  u        cr cn|||||||||130605s2013    njuad   sb    001 0 eng d  z  2013005181  z9781118312063  z9781118312056  z9781118312155 (cloth)  z9781118312131 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)84991470214aRJ560b.P43 2013eb00aPediatric drug developmenth[electronic resource] :bconcepts and applications /ceditors, Andrew E. Mulberg ... [et al.].  a2nd ed.  aHoboken, N.J. :bWiley,c2013.  axiv, 610 p. :bill. (some col.)  aIncludes bibliographical references and index.0 apt. I. Past, present, and future of pediatric drug development -- pt. II. Ethical underpinnings -- pt. III. Regulatory guidelines for pediatric drug development -- pt. IV. Preclinical safety assessment -- pt. V. Pharmacological principles in pediatric drug development -- pt. VI. Clinical trial operations -- pt. VII. Clinical trial operations and good clinical trials -- pt. VIII. Clinical efficacy and safety endpoints -- pt. IX. Formulation, chemistry and manufacturing controls.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aPediatric pharmacology. 0aDrug development. 7aElectronic books.2local1 aMulberg, Andrew E.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10713652zAn electronic book accessible through the World Wide Web; click to view  c629d629